Arkolith/Insider Trading/AVXL/Form 4

Thomas Steffen

DirectorANAVEX LIFE SCIENCES CORP. (AVXL) · full profile →Form 4 · filed May 17, 2024
Net Buying
Open-Market Buys
$23K
Open-Market Sells
$0
Net Open-Market Flow
$23K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2024Buy(P)5K$4.52$23K5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-24-000828) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML